US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY MANAGED FUTURES STRATEGY ETF

29.08

+0.81002.87%

Volume:402.16K

Turnover:11.62M

Market Cap:1.65B

PE:- -

High:29.10

Open:28.52

Low:28.50

Close:28.27

52wk High:32.76

52wk Low:25.39

Shares:56.85M

Float Shares:56.85M

Volume Ratio:1.20

T/O Rate:0.71%

Dividend:1.43

Dividend Rate:4.91%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Mid-Year Outlook for Major Asset Classes in 2026: Shared Views and Scarcity

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

Goldman Sachs Cautions On US Stocks: Geopolitical Momentum Stalls, Asymmetric CTA Downside Risks Emerge

Goldman Sachs Cautions on US Stocks: Geopolitical Momentum Stalls, Asymmetric Downside Risk from CTAs Emerges

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

Three Key Forces Propel US Stocks to Nine-Week Winning Streak

Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease

Hisense เปิดตัว UR8 ด้วยสีสันที่เป็นธรรมชาติและสมจริง นำเทคโนโลยี RGB MiniLED รุ่นใหม่สู่ครอบครัว

Hisense Perkenal UR8 dengan Warna Semula Jadi dan Realistik, Bawa Teknologi RGB MiniLED Generasi Baharu ke Lebih Banyak Kediaman

Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade

Global Long-Term Bond Yields Soar, Pressuring Equity Markets; Silver Gains 2%

U.S. Treasury Bulls Capitulate En Masse as CTA, Asset Managers, and Japanese Investors Retreat, Signaling Potential Greater Turmoil Ahead

U.S. Treasury Bond Bulls Capitulate: CTAs, Asset Managers, and Japanese Investors Simultaneously Retreat, Signaling Potential Turmoil Ahead

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial

ProQR Announces First Quarter 2026 Operating and Financial Results

Gold overtakes dollar reserves as global trust shifts

Press Release: Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates

Press Release: Entrada Therapeutics Reports First Quarter 2026 Financial Results

Immunocore reports first quarter financial results and provides a business update

Strategy Shares Down 1.1% Premarket After Co Posts Wider Quarterly Loss

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/CTA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTA\",,,,,undefined,":{"symbol":"CTA","market":"US","secType":"STK","nameCN":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","latestPrice":29.08,"timestamp":1788284764378,"preClose":28.27,"halted":0,"volume":402161,"delay":0,"changeRate":0.028652281570569465,"floatShares":56850001,"shares":56850001,"eps":0,"marketStatus":"Trading","change":0.81,"latestTime":"09-01 13:46:09 EDT","open":28.52,"high":29.1,"low":28.5001,"amount":11622072.455694,"amplitude":0.02122,"askPrice":29.09,"askSize":800,"bidPrice":29.04,"bidSize":600,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":28.27,"sharesOutstanding":45800001,"nav":27.5706,"aum":1552169050.31,"dividendRate":0.049106,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":28.59,"preClose":28.27,"latestTime":"08:53 EDT","volume":297,"amount":8488.990026,"timestamp":1788267229618,"change":0.32,"changeRate":0.011319,"amplitude":0.011319},"postHourTrading":{"tag":"盘后","latestPrice":28,"preClose":28.27,"latestTime":"19:55 EDT","volume":2619,"amount":73376.53,"timestamp":1788220502416,"change":-0.27,"changeRate":-0.009551,"amplitude":0.010612},"volumeRatio":1.1976,"impliedVol":0.1752,"impliedVolPercentile":0.6746},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTA\",,,,,undefined,":{"symbol":"CTA","floatShares":56850001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1976,"shares":56850001,"dividePrice":1.428,"high":29.1,"amplitude":0.02122,"preClose":28.27,"low":28.5001,"week52Low":25.39,"pbRate":"--","week52High":32.76,"institutionHeld":0,"latestPrice":29.08,"committee":-0.142857,"eps":0,"divideRate":0.049106,"volume":402161,"delay":0,"ttmEps":0,"open":28.52,"prevYearClose":27.26,"prevWeekClose":27.5223,"prevMonthClose":28.27,"prevQuarterClose":25.94,"fiveDayClose":27.01,"twentyDayClose":25.45,"sixtyDayClose":29.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTA\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"CTA","amount":0.13,"announcedDate":"2026-08-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-26","defaultRemindTime":1787751000000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-31","payableDate":"2026-08-26","currency":"USD","dateTimestamp":1787716800000,"payDate":"2026-08-31"},{"date":"2026-07-28","symbol":"CTA","amount":0.13,"announcedDate":"2026-07-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-28","defaultRemindTime":1785245400000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-28","currency":"USD","dateTimestamp":1785211200000,"payDate":"2026-07-31"},{"date":"2026-06-25","symbol":"CTA","amount":0.13,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-05-26","symbol":"CTA","amount":0.15,"announcedDate":"2026-05-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-26","defaultRemindTime":1779802200000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-26","currency":"USD","dateTimestamp":1779768000000,"payDate":"2026-05-29"},{"date":"2026-04-27","symbol":"CTA","amount":0.15,"announcedDate":"2026-04-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-27","defaultRemindTime":1777296600000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-27","currency":"USD","dateTimestamp":1777262400000,"payDate":"2026-04-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTA\",market:\"US\",,,undefined,":[{"executeDate":"2022-08-26","recordDate":"2022-08-29","paymentDate":"2022-08-31","value":0.15,"currency":"USD"},{"executeDate":"2022-09-27","recordDate":"2022-09-28","paymentDate":"2022-09-30","value":0.15,"currency":"USD"},{"executeDate":"2022-10-26","recordDate":"2022-10-27","paymentDate":"2022-10-31","value":0.15,"currency":"USD"},{"executeDate":"2022-11-25","recordDate":"2022-11-28","paymentDate":"2022-11-30","value":0.15,"currency":"USD"},{"executeDate":"2022-12-27","recordDate":"2022-12-28","paymentDate":"2022-12-30","value":1.11096,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1189451654","title":"Mid-Year Outlook for Major Asset Classes in 2026: Shared Views and Scarcity","url":"https://stock-news.laohu8.com/highlight/detail?id=1189451654","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189451654?lang=en_us&edition=fundamental","pubTime":"2026-06-26 17:27","pubTimestamp":1782466032,"startTime":"0","endTime":"0","summary":"The first half of 2026 has been a period of stark divergence in asset performance, with technology assets delivering exceptional returns while traditional safe havens have faltered. This analysis...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA","BK4535","PALL","GOLY","GLL","UYM","BTGD","UBmain","AAAU","SGUmain","BGLD","PICK","UGL","BWX","DGZ","IGOV","CEF","IEI","KGLD","SGOL","BBLB","RING","TNmain","SHNY","MGCmain","GCmain","BBSB","JNUG","SGCmain","TLTW","GDXY","TLTX","IAUI","NUGT","USG","BK4504","BK4581","TLTI","SHV","GLD","TBJL","GLDM","TFJL","BWZ","GOAU","TSYW","IAU","VGT","GDX","IAUM","IEF","ZFmain","GOLI","DZZ","UDN","GLDY","ZBmain","DBC","DGP","FGDL","GDXD","JDST","TLH","SHY","DULL","GBUG","IGLD","ZTmain","PHYS","GDXU","FLGV","BK4585","SGDM","GLTR","ZNmain","BBIB","ISHG","DUST","XME","YGLD","BK4207","518880","GDXJ","159934","SGOV","BEGS","UUP","BAR","BK4588","OUNZ","TLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646714368","title":"ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2646714368","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646714368?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:25","pubTimestamp":1782383100,"startTime":"0","endTime":"0","summary":"Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the evaluable 3 mg/kg and 6 mg/kg cohortsAX-0810 demonstrated up","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/25/3317367/33039/en/ProQR-Announces-Positive-Phase-1-Target-Engagement-Data-for-AX-0810-Establishing-First-Clinical-Validation-of-the-Axiomer-RNA-Editing-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","LU2092937221.SGD","BK4551","BOEG","AX","BK4226","BK4523","LU1165135440.EUR","BK4106","LU0072461881.USD","LU1435385759.SGD","LU2413666426.HKD","BK4516","BOED","LU0702159699.USD","BK4121","RNA","LU0702159343.USD","CTA","LU1166156734.SGD","LU2229751404.USD","LU0162691827.USD","LU0347712357.USD","BK4211","BA","BK4187","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","BK4139","BK4585","IE00BN0W2V16.EUR","BK4195","LU1861217088.USD","LU1543694498.USD","LU2360107671.USD","A","IE000M9KFDE8.USD","LU2089279066.USD","LU1429558221.USD","IE0009354923.USD","LU1721428933.USD","BK4588","LU1861220207.SGD","LU2326559502.SGD","BK4505","LU2041044095.USD","BK4564","G","BOEU","LU2413666699.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104193547","title":"Goldman Sachs Cautions On US Stocks: Geopolitical Momentum Stalls, Asymmetric CTA Downside Risks Emerge","url":"https://stock-news.laohu8.com/highlight/detail?id=1104193547","media":"Stock News","labels":["economic","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104193547?lang=en_us&edition=fundamental","pubTime":"2026-06-20 07:41","pubTimestamp":1781912460,"startTime":"0","endTime":"0","summary":"In a week with only four trading sessions, the US stock market concluded with a sharp rally into the Friday holiday and options expiration, with AI-related themes once again serving as the primary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPRO","HIBL","DXD","SMAX","LU0061475181.USD","LU2237443978.SGD","IVV","IE00BFXG1179.USD","LU0742534661.SGD","LU0048573561.USD","IE00BSNM7G36.USD","DIA","LU2471134796.USD","SPXU","LU2237443465.HKD",".IXIC","IE00B19Z3B42.SGD","LU1791807156.HKD","LU1868836914.USD","GSX",".DJI","LU2237443382.USD","LU0345770308.USD","CTA","DMAX","SPYM","SPYQ","SPUU","IE0004091025.USD","LU2237443895.HKD","LU0251131958.USD","BK4588","BK4504","DDM","LU2471134952.CNY","SH","LU1804176565.USD","LU0106831901.USD","LU2237443622.USD","LU2237443549.SGD","SPYU","BK4550","LU0345770993.USD","BK4533","BK4585","LU1668664300.SGD","LU1868837300.USD","BK4552","SPXS","LU0096364046.USD","UDOW","SPDN","LU1894683348.USD","SSO","BK4127","MMAX","LU1868837136.USD",".SPX","IE00B19Z3581.USD","YSPY","LU1894683264.USD","DOG","LU0942090050.USD","LU0868494708.USD","LU0868494617.USD","SDS","IE0034235188.USD","SPXL","VOO","IE0004086264.USD","IE0002270589.USD","LU1868836591.USD","SDOW","LU2750360641.GBP","GS","LU2750360997.AUD","LU2237438978.USD","LU2265009873.SGD","LU1868836757.USD","BK4516","SPY","LU2471134879.HKD","LU2471134523.USD","LU0251142724.SGD","SPYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167814579","title":"Goldman Sachs Cautions on US Stocks: Geopolitical Momentum Stalls, Asymmetric Downside Risk from CTAs Emerges","url":"https://stock-news.laohu8.com/highlight/detail?id=1167814579","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167814579?lang=en_us&edition=fundamental","pubTime":"2026-06-20 06:10","pubTimestamp":1781907058,"startTime":"0","endTime":"0","summary":"US stocks concluded a four-trading-day week with a sharp rally into Friday's holiday and options expiration, with AI-related themes once again serving as the primary upward catalyst. However, Goldman...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","IE0002270589.USD","LU1804176565.USD","LU2237443465.HKD","IE0004086264.USD","CTA","BK4533","GS","LU2237443895.HKD","LU0251142724.SGD","IE00B19Z3581.USD","LU0048573561.USD","BK4516","LU0061475181.USD","LU0096364046.USD","LU2471134523.USD","LU1894683264.USD","IE0034235188.USD","LU2471134952.CNY","LU0345770993.USD","IE00BFXG1179.USD","LU0345770308.USD","LU0942090050.USD","LU2237443978.SGD","LU2471134879.HKD","IE00B19Z3B42.SGD","LU2237443382.USD","BK4585","LU2237443622.USD","LU1668664300.SGD","LU2471134796.USD","BK4550","LU2237438978.USD","LU0251131958.USD","LU0742534661.SGD","LU0868494708.USD","LU1868836591.USD","BK4552","LU0868494617.USD","LU2750360997.AUD","LU1791807156.HKD","BK4588","LU0106831901.USD","GSX","LU1894683348.USD","LU1868837300.USD","LU1868837136.USD","LU2265009873.SGD","LU1868836757.USD","LU2237443549.SGD","BK4504","LU1868836914.USD","IE0004091025.USD","LU2750360641.GBP","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644908518","title":"Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2644908518","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644908518?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:00","pubTimestamp":1781784000,"startTime":"0","endTime":"0","summary":"-- First clinical authorization for an in vivo Prime Editing therapy from Prime Medicine -- -- PM577a targets the H1069Q mutation in the ATP7B gene, the most prevalent WD-causing allele in North Ameri","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/18/3314111/0/en/Prime-Medicine-Announces-New-Zealand-Clearance-of-Clinical-Trial-Application-for-PM577a-in-H1069Q-mutated-Wilson-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICOP","COPJ","CTA","BK4229","BK4195","CPXR","XME","WD","BK4535","UYM","CPER","COPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132040702","title":"Three Key Forces Propel US Stocks to Nine-Week Winning Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=1132040702","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132040702?lang=en_us&edition=fundamental","pubTime":"2026-06-02 14:41","pubTimestamp":1780382461,"startTime":"0","endTime":"0","summary":"The S&P 500 has closed higher for nine consecutive weeks, gaining 5% in May and is poised to extend its run to ten weeks—a feat not seen since 1985.Amidst concerns over geopolitical tensions, private...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638656566","title":"Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2638656566","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638656566?lang=en_us&edition=fundamental","pubTime":"2026-05-28 10:43","pubTimestamp":1779936180,"startTime":"0","endTime":"0","summary":"Coronary artery disease  remains a leading cause of morbidity and mortality globally, driven by atherosclerotic plaque formation and associated thrombotic complications such as myocardial infarction and other ischemic events. Despite the widespread use of standard of care therapies, including antiplatelet and anticoagulant therapies, a substantial residual risk of thrombotic events remains in patients with stable CAD, even when treated with optimized treatment. Current therapies are further limited by an increased risk of bleeding, restricting their intensity and long-term use in many patients. Consequently, there is a significant unmet medical need for novel antithrombotic approaches that can provide effective and sustained protection against thrombosis while maintaining a favorable safety profile, particularly with respect to bleeding risk.\"We are very pleased to advance our anti-thrombotic siRNA programs into the next stage of clinical development in Europe. This milestone reflects ","market":"other","thumbnail":"https://mma.prnewswire.com/media/2804420/logo_Ribolia_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2804420/logo_Ribolia_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ribo-announces-phase-2-clinical-trial-submission-to-ema-further-advancing-sirna-therapeutics-in-thromboembolic-disease-302783857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA","BK4007","EMA.AU","BK7129","BK7504","BK4539","BK4081","EMA","BK7095","BK4139","CAD.AU","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637908523","title":"Hisense เปิดตัว UR8 ด้วยสีสันที่เป็นธรรมชาติและสมจริง นำเทคโนโลยี RGB MiniLED รุ่นใหม่สู่ครอบครัว","url":"https://stock-news.laohu8.com/highlight/detail?id=2637908523","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637908523?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:00","pubTimestamp":1779440400,"startTime":"0","endTime":"0","summary":", ,22  2569 /PRNewswire/ -- Hisense   UR8  RGB MiniLED. RGB MiniLED Hisense  RGB MiniLED   Chromagic  Hisense  Chromagic RGB     UR8   BT.2020 100%      \"RGB LED\"   Hisense   RGB MiniLED. UR8  Hi-View AI Engine RGB     180Hz     2.1.2  Devialet. Hisense  RGB MiniLED  UR8     UR8  HisenseHisense 2512 160    OmdiaHisense1100 RGB MiniLEDHisenseRGB MiniLED FIFA Club World Cup 2026SOURCE Hisense","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2982963/UR8_18x9_TR.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2982963/UR8_18x9_TR.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hisense--ur8---rgb-miniled--302776252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637901893","title":"Hisense Perkenal UR8 dengan Warna Semula Jadi dan Realistik, Bawa Teknologi RGB MiniLED Generasi Baharu ke Lebih Banyak Kediaman","url":"https://stock-news.laohu8.com/highlight/detail?id=2637901893","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637901893?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:00","pubTimestamp":1779440400,"startTime":"0","endTime":"0","summary":"QINGDAO, China, 22 Mei 2026 /PRNewswire/ -- Hisense, jenama terkemuka global dalam elektronik pengguna dan perkakas rumah, hari ini memperkenalkan UR8, siri TV RGB MiniLED mampu milik yang direka untuk membawa teknologi paparan generasi baharu, warna semula jadi dan realistik, hiburan imersif serta prestasi permainan video termaju kepada lebih ramai pengguna di seluruh dunia.Menerusi UR8, Hisense terus mempercepat penggunaan teknologi RGB MiniLED, sekali gus menjadikan inovasi paparan generasi baharu lebih mudah diakses pengguna global. Menggabungkan prestasi imej termaju, pemprosesan pintar dan reka bentuk sofistikated, UR8 mewakili satu lagi langkah besar ke hadapan dalam masa depan hiburan rumah premium.Latar Belakang HisenseDitubuhkan pada tahun 1969, Hisense merupakan peneraju global yang diiktiraf dalam bidang perkakas rumah dan elektronik pengguna dengan operasi di lebih 160 negara, khusus dalam penyediaan produk multimedia berkualiti tinggi, perkakas rumah dan penyelesaian IT p","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2982962/UR8_18x9_TR.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2982962/UR8_18x9_TR.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hisense-perkenal-ur8-dengan-warna-semula-jadi-dan-realistik-bawa-teknologi-rgb-miniled-generasi-baharu-ke-lebih-banyak-kediaman-302776135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636840428","title":"Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2636840428","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636840428?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:45","pubTimestamp":1779281100,"startTime":"0","endTime":"0","summary":"Plans to File CTA for Ph. 1b, FIH Study, 30 – 40 Advanced Cancer Patients in ‘26MELBOURNE, Australia, May  20, 2026  (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Compa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/20/3298501/0/en/Propanc-Biopharma-s-CEO-Forecasts-New-Medical-Breakthroughs-in-the-Fight-Against-Pancreatic-Cancer-Over-the-Next-Decade.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165357663","title":"Global Long-Term Bond Yields Soar, Pressuring Equity Markets; Silver Gains 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165357663","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165357663?lang=en_us&edition=fundamental","pubTime":"2026-05-20 15:37","pubTimestamp":1779262639,"startTime":"0","endTime":"0","summary":"As inflation expectations rise following the Iran conflict, bond yields have surged significantly. The deep divergence between stock and bond markets has prompted multiple institutions to issue...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DUG","UUP","CTA","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157043430","title":"U.S. Treasury Bulls Capitulate En Masse as CTA, Asset Managers, and Japanese Investors Retreat, Signaling Potential Greater Turmoil Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=1157043430","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157043430?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:16","pubTimestamp":1779192981,"startTime":"0","endTime":"0","summary":"The U.S. Treasury market is witnessing a broad capitulation among bullish investors. According to Bank of America's latest research report on May 19, long positions across the Treasury yield curve...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLGV","NGHT","ZTmain","BIL","TFJL","BITC","UBT","VCSH","ZROZ","GOLY","DBND","SHV","TLTW","ZBmain","TYO","UFIV","HYG","BK4561","UTHY","VGIT","BND","UBmain","UTWY","MINT","MWNmain","BOND","BBLB","BNDW","SGOV","MUB","SHY","TBJL","BK4581","TNmain","IEI","BK4535","LQD","ZFmain","TIP","TMF","SCHO","BBIB","BK4585","BBSB","AGG","GBIL","BWZ","IGOV","TLH","GOVT","BK4588","CTA","ZNmain","BK4550","EDV","MTNmain","IEF","TSYW","USHY","VGSH","VGLT","BWX","TBT","VCIT","ISHG","TLTI","BSV","TLTX","TBIL","BK4504","UTRE","TLT","JPST","USVN","BOXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121286287","title":"U.S. Treasury Bond Bulls Capitulate: CTAs, Asset Managers, and Japanese Investors Simultaneously Retreat, Signaling Potential Turmoil Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=1121286287","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121286287?lang=en_us&edition=fundamental","pubTime":"2026-05-19 16:03","pubTimestamp":1779177834,"startTime":"0","endTime":"0","summary":"The U.S. Treasury market is witnessing a rare capitulation among bullish investors. On May 19, according to reports from trading desks, Bank of America Merrill Lynch's latest research indicates that...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLTX","ZFmain","BK4535","TLTW","ZTmain","TSYW","BBSB","BK4550","BBLB","BBIB","BOXX","FLGV","ZBmain","IGOV","ISHG","IEI","TBT","TFJL","TYO","UFIV","TLTI","ZNmain","UTRE","UTWY","BK4588","DBND","EDV","UTHY","ZROZ","CTA","MTNmain","MWNmain","BWX","MINT","UBT","UBmain","VCSH","VGSH","SCHO","TLH","VGLT","GOVT","NGHT","SHV","LQD","BITC","VGIT","MUB","TBJL","TMF","BWZ","GBIL","TNmain","BND","GOLY","IEF","BK4581","TLT","BK4585","SGOV","VCIT","BK4561","BNDW","TIP","BSV","JPST","TBIL","AGG","BK4504","BIL","HYG","BOND","SHY","USVN","USHY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635780133","title":"Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635780133","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635780133?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:25","pubTimestamp":1778678700,"startTime":"0","endTime":"0","summary":"Raanana, Israel, May  13, 2026  (GLOBE NEWSWIRE) --  Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative int","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3294087/0/en/Polyrizon-Advances-Towards-Human-Clinical-Trials-Secures-First-U-S-Clinical-Site-for-NASARIX-Allergy-Blocker-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634137322","title":"ProQR Announces First Quarter 2026 Operating and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634137322","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634137322?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"AX-0810 target engagement data in healthy volunteers on track for Q2 2026; biliary atresia selected as initial Phase 2 indicationPipeline expansion with advancement of AX-0811 (NTCP) and AX-0422 (IDUA","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292670/33039/en/ProQR-Announces-First-Quarter-2026-Operating-and-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0702159343.USD","IE00BN0W2T93.GBP","BK4551","BOEG","BA","LU0347712357.USD","LU1429558221.USD","LU2229751404.USD","LU2041044095.USD","LU2413666426.HKD","RNA","BK4121","LU0702159699.USD","CTA","IE000M9KFDE8.USD","BK4106","BK4505","IE0009354923.USD","LU2326559502.SGD","IE00BN0W2V16.EUR","LU1435385759.SGD","BK4226","G","LU2089279066.USD","LU1721428933.USD","BK4187","BK4516","BK4139","LU1165135440.EUR","LU1166156734.SGD","LU2092937221.SGD","A","BK4585","LU1543694498.USD","BOED","IE00BN0W2W23.USD","BK4564","LU2413666699.HKD","BK4523","BK4588","BK4567","BOEU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253293","title":"Gold overtakes dollar reserves as global trust shifts","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253293","media":"Kitco","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253293?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:54","pubTimestamp":1778500440,"startTime":"0","endTime":"0","summary":"Key TakeawaysGold Reclaims Monetary Leadership: Gold has overtaken U.S. dollar reserves globally, reinforcing its role as the primary neutral reserve asset amid eroding confidence in the dollar system","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"kitco_highlight","url":"https://www.kitco.com/opinion/2026-05-11/gold-overtakes-dollar-reserves-global-trust-shifts","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.kitco.com/opinion/2026-05-11/gold-overtakes-dollar-reserves-global-trust-shifts","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kitco_highlight","symbols":["GDXJ","UDN","RING","159934","GCmain","USG","SGDM","BTGD","GLL","GLDM","GDXU","UAE","CTA","BEGS","UYM","GDXD","FGDL","1OZmain","XME","BAR","JNUG","MGCmain","DULL","IAUI","DUST","GLTR","SGCmain","GDX","IAUM","JDST","PHYS","PICK","GDXY","RMP","GDP","DZZ","DBC","GBUG","UUP","CEF","SGOL","GOLY","IAU","OUNZ","UGL","GOAU","DGP","SHNY","AAAU","AGQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144834","title":"Press Release: Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144834","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144834?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:00","pubTimestamp":1778155200,"startTime":"0","endTime":"0","summary":"-- On track to file IND and/or CTA for PM577 in Wilson. Disease in H1 2026 and for PM647 in AATD mid-2026;-- Continued regulatory dialogue with the FDA toward. cash of $149.2 million as of March 31, 2026, providing. Prime Medicine is currently advancing in vivo programs to cure two of the largest genetic liver diseases, Wilson Disease  and Alpha-1 Antitrypsin Deficiency . Prime Medicine expects to file an Investigational New Drug application  and/or Clinical Trial Application  for PM577 in WD in the first half of 2026 and for PM647 in AATD in mid-2026; initial clinical data from both programs are expected in 2027.Prime Medicine is also advancing an in vivo Cystic Fibrosis  program with support from the Cystic Fibrosis Foundation, and efforts to develop Prime Edited CAR-T products for hematology, immunology and oncology in partnership with Bristol Myers Squibb. Additionally, following positive proof-of-concept data from the first two patients treated in its Phase 1/2 study of PM359 for ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4229","CF","BK4195","CFO","WD","BK4585","PRME","BK4588","IND","CTA","BK4093","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633146327","title":"Press Release: Entrada Therapeutics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633146327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633146327?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:10","pubTimestamp":1778152200,"startTime":"0","endTime":"0","summary":"-- Announced positive ELEVATE-44-201 Cohort 1 topline results in Duchenne muscular dystrophy showing favorable safety, tolerability and early functional benefit --. -- Company on track to report ELEVATE-45-201 Cohort 1 data in mid-2026, as well as ELEVATE-44-201 open-label period and Cohort 2 data by year-end 2026 --. -- Cash runway expected into Q3 2027 with $255 million in cash, cash equivalents and marketable securities as of March 31, 2026 --. BOSTON, May 07, 2026  -- Entrada Therapeutics, Inc.  today reported financial results for the first quarter ended March 31, 2026, and highlighted recent business updates.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA","TRDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633182528","title":"Immunocore reports first quarter financial results and provides a business update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633182528","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633182528?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:00","pubTimestamp":1778065200,"startTime":"0","endTime":"0","summary":"Immunocore reports first quarter financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q1 net sales of $106.7 million, growing by 14% year-over-year Oral presentation at AACR: K","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288641/0/en/Immunocore-reports-first-quarter-financial-results-and-provides-a-business-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG0V08.USD","IE00B7SZL793.SGD","IE00B5TLWC47.USD","PROC","BK4195","CRS","IE00BYQQ9H92.USD","IE0031619046.USD","BK4139","BK4121","ATOM","BK4006","CTA","IE00B19Z4B17.USD","IND","MTD","BK4007","LU1721428933.USD","ALT","BK4548","LU0347712357.USD","LU2413666426.HKD","CM","LU0963586101.USD","BK4187","LU1093756168.USD","BK4207","ORR","LU2211817866.USD","IE00B66KJ199.SGD","LU2413666699.HKD","BK4585","BK4588","LU1878469433.USD","LU1093756325.SGD","PFS","BK4567","LU2065731478.USD","BK4211","BK4599","BK4533","BK4147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633590220","title":"Strategy Shares Down 1.1% Premarket After Co Posts Wider Quarterly Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2633590220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633590220?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:08","pubTimestamp":1778054908,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL4N41J0OG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NZRO","BK4588","MSTK","LMI3.UK","MSOO","MSII","WNTR","XAUUSD.FOREX","BK4600","MSTW","MTYY","IMST","MSTY","BK4516","GOLY","SMI3.UK","MSDD","09799","09399","ROMO","07399","BK4023","APED","MST","FIVR","MSTY.UK","HNDL","07799","MSTU","MSTZ","SMST","BK4596","MSST","3LMI.UK","MSTP","BK4595","MSTX","BGLD","CTA","3SMI.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":91,"code":"91000000","status":"200"}]}}